Medical technology company Healthcare Holding Schweiz AG announced on Monday that it has completed the acquisition of Effectum CH-Rep AG, effectively carving out all Swiss Authorized Representative (CH-REP) services from Effectum Medical AG.
Under the Medical Devices Ordinance (MedDO SR 812.213), medical device manufacturers without a Swiss presence must appoint a CH-REP to distribute products within Switzerland.
This acquisition enhances Healthcare Holding Schweiz AG's ability to serve as a comprehensive partner for global medical technology manufacturers. The company's expanded portfolio now includes services ranging from import and distribution to full regulatory compliance. This positions Healthcare Holding Schweiz AG to offer integrated solutions to meet evolving industry needs.
D2 Solutions acquires ProModRx
Orthocell gains approval for Remplir across US defence and veterans hospital networks
QT Imaging Debuts QT Imaging-Olea Viewer for integrated multimodality breast imaging
CS Analytical appoints director of Scientific Affairs
MedPal AI launches integrated health OS platform to drive scalable digital healthcare
CenExel appoints Dr. Sy Pretorius as CEO
QT Imaging launches next-generation breast imaging reconstruction software
Tempus and Medtronic report positive ALERT trial results for AI-driven cardiac care
US FDA approves i-Lumen Scientific's i-SIGHT2 clinical study for dry AMD
Edwards Lifesciences reports positive two-year data for EVOQUE valve system
Clarity Pharmaceuticals signs copper-64 manufacturing agreement with Theragenics
Thermo Fisher Scientific and SHL Medical launch integrated US drug-device manufacturing
Philips launches integrated IntraSight Plus platform to enhance coronary intervention efficiency
Laronix and Greater Baltimore Medical Center launch Laronix MIRA Voice investigational study